Interstitial lung abnormalities a risk factor for rheumatoid arthritis interstitial lung disease progression: what's new
- PMID: 33664837
- PMCID: PMC7910034
- DOI: 10.1183/20734735.0223-2020
Interstitial lung abnormalities a risk factor for rheumatoid arthritis interstitial lung disease progression: what's new
Abstract
ILA/ILD extension and subpleural ILA localisation are risk factors for disease progression in RA subjects. A semiquantitative method to assess ILA/ILD extent and to measure the fibrotic burden is feasible to accurately determine ILA progression. https://bit.ly/3mmMJk2.
Copyright ©ERS 2021.
Conflict of interest statement
Conflict of interest: P.M. Leone has nothing to disclose. Conflict of interest: L. Richeldi reports personal fees from Boehringer Ingelheim, personal fees from Roche, personal fees from Sanofi-Aventis, personal fees from Promedior, personal fees from Chiesi, personal fees from GlaxoSmithKline, outside the submitted work.
References
Publication types
LinkOut - more resources
Full Text Sources
Research Materials